Overview

Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the potential effect of CP 690,550 on the pharmacokinetics of metformin, a probe drug for organic cationic transport.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Metformin
Tofacitinib